Apple has filed an appeal after the Biden administration allowed a U.S. ban on its watch imports. Masimo, a medical monitoring tech company, complained about Apple’s alleged use of its pulse oximetry technology in the Apple Watch.

Despite President Biden’s administration not vetoing the ban, Apple is taking steps to challenge the decision. The company filed an emergency request with the U.S. Court of Appeals to halt the ban until U.S. Customs and Border Protection reviews redesigned watch versions for patent infringement.

Masimo claims Apple hired its employees and incorporated its technology, leading to the ban by the U.S. International Trade Commission (ITC). The ITC’s order prevents the import and sale of Apple Watches reading blood-oxygen levels.

U.S. Trade Representative Katherine Tai supported the ITC’s decision, stating consultations were thorough. Apple, however, strongly disagrees and has appealed to the U.S. Court of Appeals.

The ITC rejected Apple’s request to pause the ban during the appeal, prompting the tech giant to halt sales of its Series 9 and Ultra 2 smartwatches in the U.S. The ban does not impact the less-expensive Apple Watch SE.

While Apple usually settles such disputes, the ITC order remains in effect. Experts suggest the appeal process could extend the case verdict by about a year.

The Biden administration’s decision not to veto the ban echoes a similar move in February, when an import ban on Apple Watches was based on a patent-infringement complaint from AliveCor. Apple’s wearables business generated $8.28 billion in revenue during Q3 2023.

Conclusion

Apple faces a significant challenge in overturning the ban on its watches. For more information on the ongoing legal battle and updates on this issue, consider visiting 4xpip.com. Explore our website for valuable insights into the stock market, cryptocurrency, and forex trading. Don’t miss out on the latest news and expert advice. Reach out to our customer support at [email protected] for additional guidance.